Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0000122 |
IEA |
negative regulation of transcription from RNA polymerase II promoter |
GO:0000979 |
IDA |
RNA polymerase II core promoter sequence-specific DNA binding |
GO:0000981 |
IEA |
sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0000983 |
IDA |
RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity |
GO:0001077 |
IDA |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0001105 |
IDA |
RNA polymerase II transcription coactivator activity |
GO:0001106 |
IDA |
RNA polymerase II transcription corepressor activity |
GO:0001158 |
IEA |
enhancer sequence-specific DNA binding |
GO:0001822 |
IMP |
kidney development |
GO:0003091 |
IMP |
renal water homeostasis |
GO:0003682 |
IEA |
chromatin binding |
GO:0003700 |
ISS |
sequence-specific DNA binding transcription factor activity |
GO:0003713 |
IDA |
transcription coactivator activity |
GO:0003714 |
IEA |
transcription corepressor activity |
GO:0005515 |
IPI |
protein binding |
GO:0005634 |
ISS |
nucleus |
GO:0006006 |
ISS |
glucose metabolic process |
GO:0006355 |
ISS |
regulation of transcription, DNA-templated |
GO:0006366 |
IDA |
transcription from RNA polymerase II promoter |
GO:0007423 |
IEP |
sensory organ development |
GO:0008284 |
IMP |
positive regulation of cell proliferation |
GO:0008285 |
ISS |
negative regulation of cell proliferation |
GO:0010226 |
IEA |
response to lithium ion |
GO:0010842 |
IEA |
retina layer formation |
GO:0010960 |
IMP |
magnesium ion homeostasis |
GO:0030510 |
IMP |
regulation of BMP signaling pathway |
GO:0035136 |
IMP |
forelimb morphogenesis |
GO:0035137 |
IMP |
hindlimb morphogenesis |
GO:0035810 |
IMP |
positive regulation of urine volume |
GO:0035909 |
IMP |
aorta morphogenesis |
GO:0042493 |
IEA |
response to drug |
GO:0042593 |
IMP |
glucose homeostasis |
GO:0042803 |
IEA |
protein homodimerization activity |
GO:0043027 |
IMP |
cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0043066 |
IMP |
negative regulation of apoptotic process |
GO:0043154 |
IMP |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0043524 |
IGI |
negative regulation of neuron apoptotic process |
GO:0043525 |
ISS |
positive regulation of neuron apoptotic process |
GO:0043565 |
ISS |
sequence-specific DNA binding |
GO:0043588 |
IEP |
skin development |
GO:0045444 |
IEP |
fat cell differentiation |
GO:0045595 |
ISS |
regulation of cell differentiation |
GO:0045892 |
ISS |
negative regulation of transcription, DNA-templated |
GO:0045893 |
IEA |
positive regulation of transcription, DNA-templated |
GO:0045944 |
IDA |
positive regulation of transcription from RNA polymerase II promoter |
GO:0046982 |
IEA |
protein heterodimerization activity |
GO:0046983 |
ISS |
protein dimerization activity |
GO:0048485 |
IGI |
sympathetic nervous system development |
GO:0050796 |
ISS |
regulation of insulin secretion |
GO:0055062 |
IMP |
phosphate ion homeostasis |
GO:0055074 |
IMP |
calcium ion homeostasis |
GO:0055075 |
IMP |
potassium ion homeostasis |
GO:0055078 |
IMP |
sodium ion homeostasis |
GO:0072017 |
IMP |
distal tubule development |
GO:0072044 |
IMP |
collecting duct development |
GO:0072210 |
IEP |
metanephric nephron development |
GO:0097070 |
IMP |
ductus arteriosus closure |
GO:0097275 |
IMP |
cellular ammonia homeostasis |
GO:0097276 |
IMP |
cellular creatinine homeostasis |
GO:0097277 |
IMP |
cellular urea homeostasis |